Peripheral Arterial Disease (PAD) Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)

  • May 2019
  • By 99Strategy
  • 58 pages
  • Report Id: 208920

Peripheral Arterial Disease (PAD) Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)

  • May 2019
  • By 99Strategy
  • 58 pages
  • Report Id: 208920
According to research study, the Global Peripheral Arterial Disease (PAD) Drugs Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Peripheral Arterial Disease (PAD) Drugs market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)
Key Product Type
Clopidogrel (Plavix)
Prasugrel (Effient)
Ticagrelor (Brilinta)
Vorapaxar (Zontivity)
Others
Market by Application
Hospitals
Clinics
Others
Main Aspects covered in the Report
Overview of the Peripheral Arterial Disease (PAD) Drugs market including production, consumption, status & forecast and market growth
2015-2018 historical data and 2019-2025 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development
Table of Content
1 Industrial Chain Overview
1.1 Peripheral Arterial Disease (PAD) Drugs Industry
1.1.1 Overview
1.1.2 Characteristics of Peripheral Arterial Disease (PAD) Drugs
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Clopidogrel (Plavix)
1.3.2 Prasugrel (Effient)
1.3.3 Ticagrelor (Brilinta)
1.3.4 Vorapaxar (Zontivity)
1.3.5 Others
1.4 End-Use List
1.4.1 Demand in Hospitals
1.4.2 Demand in Clinics
1.4.3 Demand in Others
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2015-2025
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025
2 Global Production & Consumption by Geography
2.1 Global Production & Consumption
2.1.1 Global Production
2.1.2 Global Consumption
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
2.2.1.2 North America
2.2.1.3 South America
2.2.1.4 Europe
2.2.1.5 Middle East & Africa
2.2.2 Consumption
2.2.2.1 Asia-Pacific
2.2.2.2 North America
2.2.2.3 South America
2.2.2.4 Europe
2.2.2.5 Middle East & Africa
3 Major Manufacturers Introduction
3.1 Manufacturers Overview
3.2 Manufacturers List
3.2.1 AstraZeneca Plc. (UK) Overview
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Bayer HealthCare Pharmaceuticals (Germany) Overview
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Bristol-Myers Squibb Company (US) Overview
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Merck & Co., Inc. (US) Overview
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 Proteon Therapeutics, Inc. (US) Overview
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Sanofi S.A. (France) Overview
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Symic Bio, Inc. (US) Overview
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 TheraVasc Inc. (US) Overview
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning

4 Market Competition Pattern
4.1 Market Size and Sketch
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment
5.1 Global Overview by Product Type Segment
5.2 Segment Subdivision by Product Type
5.2.1 Market in Clopidogrel (Plavix)
5.2.1.1 Market Size
5.2.1.2 Situation & Development
5.2.2 Market in Prasugrel (Effient)
5.2.2.1 Market Size
5.2.2.2 Situation & Development
5.2.3 Market in Ticagrelor (Brilinta)
5.2.3.1 Market Size
5.2.3.2 Situation & Development
5.2.4 Market in Vorapaxar (Zontivity)
5.2.4.1 Market Size
5.2.4.2 Situation & Development
5.2.5 Market in Others
5.2.5.1 Market Size
5.2.5.2 Situation & Development
6 End-Use Segment
6.1 Global Overview by End-Use Segment
6.2 Segment Subdivision
6.2.1 Market in Hospitals
6.2.1.1 Market Size
6.2.1.2 Situation & Development
6.2.2 Market in Clinics
6.2.2.1 Market Size
6.2.2.2 Situation & Development
6.2.3 Market in Others
6.2.3.1 Market Size
6.2.3.2 Situation & Development
7 Market Forecast & Trend
7.1 Regional Forecast
7.2 Consumption Forecast
7.2.1 Product Type Forecast
7.2.2 End-Use Forecast
7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
8.2 Channel Segment
9 Market Drivers & Investment Environment
9.1 Market Drivers
9.2 Investment Environment
10 Research Conclusion

Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025
Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025
Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025
Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume
Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD
Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume
Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
Table AstraZeneca Plc. (UK) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of AstraZeneca Plc. (UK) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Bayer HealthCare Pharmaceuticals (Germany) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Bayer HealthCare Pharmaceuticals (Germany) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company (US) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Bristol-Myers Squibb Company (US) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Merck & Co., Inc. (US) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Merck & Co., Inc. (US) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Proteon Therapeutics, Inc. (US) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Proteon Therapeutics, Inc. (US) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Sanofi S.A. (France) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Sanofi S.A. (France) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Symic Bio, Inc. (US) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of Symic Bio, Inc. (US) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table TheraVasc Inc. (US) Overview List
Table Peripheral Arterial Disease (PAD) Drugs Business Operation of TheraVasc Inc. (US) (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Global Production Volume List by Manufacturers, 2015-2018, in Volume
Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume
Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD
Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume
Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume
Table Global Market Forecast by Region Segment 2019-2025, in Million USD
Table Global Market Forecast by Region Segment 2019-2025, in Volume
Table Global Market Amount by Product Type Segment 2019-2025, in Million USD
Table Global Market Volume by Product Type Segment 2019-2025, in Volume
Table Global Market Amount by End-Use Segment 2019-2025, in Million USD
Table Global Market Volume by End-Use Segment 2019-2025, in Volume